Huadong Medicine Co Ltd
SZSE:000963
Huadong Medicine Co Ltd
Cash from Financing Activities
Huadong Medicine Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Financing Activities
-¥1.2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Financing Activities
-¥6.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Financing Activities
¥231.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Financing Activities
-¥3.9B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Financing Activities
-¥632.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Cash from Financing Activities
-¥2.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
See Also
What is Huadong Medicine Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-1.2B
CNY
Based on the financial report for Sep 30, 2023, Huadong Medicine Co Ltd's Cash from Financing Activities amounts to -1.2B CNY.
What is Huadong Medicine Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-4%
Over the last year, the Cash from Financing Activities growth was -237%. The average annual Cash from Financing Activities growth rates for Huadong Medicine Co Ltd have been -18% over the past three years , -4% over the past five years .